# Wyss Center

the non-profit Wyss Center develops the fully-implanted Wyss Able ECoG system for home (not only lab) use in locked-in syndrome, and a 5-year follow-up of a fully implanted BCI in a spinal-cord-injury patient was published in 2025; its academic partners have demonstrated a streaming brain-to-voice neuroprosthesis.

Source: https://en.bioecon.ru/companies/wyss-center/
Updated: 2026-06-28

- Country: Switzerland
- Ticker: non-profit

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $50 million total investment over 8+ years at the Wyss Center prior to spinout | https://abilityneuro.com/spinout-story/, https://insidebci.com/directory/ability-neurotech/, https://www.massdevice.com/ability-neurotech-mature-implant-bci-market/ |
| Certification | ISO 13485:2016 for its Quality Management System | https://wysscenter.ch/update/the-wyss-center-receives-iso-13485-certification-by-tuv-sud-for-its-quality-management-system/ |
| Regulatory approval | Investigational Medical Device Dossier approval for a chronic clinical trial in the Netherlands | https://wysscenter.ch/update/ability-neurotech-approval-clinical-trial/ |
| Headcount | 60 employees at the Wyss Center (as of 2022) | https://www.businesswire.com/news/home/20221012005582/en/Wyss-Center-for-Bio-and-Neuroengineering-New-Horizons-in-Neural-Recording-Systems |
| Headquarters | Geneva, Switzerland | https://www.businesswire.com/news/home/20221012005582/en/Wyss-Center-for-Bio-and-Neuroengineering-New-Horizons-in-Neural-Recording-Systems, https://www.wyssfoundation.org/news/grant-in-the-spotlight-wyss-center-for-bio-and-neuroengineering, https://wysscenter.ch/about-us/ |

Independent sources: abilityneuro.com, businesswire.com, insidebci.com, massdevice.com, wyssfoundation.org

## Technologies

- [Neurointerfaces & brain–computer interfaces](https://en.bioecon.ru/technology/neurointerfaces-bci/)